Anti-CD33 monoclonal antibodies enhance the cytotoxic effects of cytosine arabinoside and idarubicin on acute myeloid leukemia cells through similarities in their signaling pathways

Experimental Hematology

Volumn 33, Issue 2, 2005, Pages 199-211

  Balaian, Larisa ^a   Ball, Edward D ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BRYOSTATIN; CD33 MONOCLONAL ANTIBODY; CYTARABINE; ETOPOSIDE; IDARUBICIN; MONOCLONAL ANTIBODY; PROTEIN KINASE LYN; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE SHP 1; PROTEIN TYROSINE PHOSPHATASE SHP 2; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ACUTE MYELOBLASTIC LEUKEMIA; ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; COLONY FORMING CELL; COMPLEX FORMATION; CONTROLLED STUDY; DRUG POTENTIATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL; WESTERN BLOTTING;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CELL LINE, TUMOR; CELL SURVIVAL; CYTARABINE; HUMANS; IDARUBICIN; LEUKEMIA, MYELOCYTIC, ACUTE; SIGNAL TRANSDUCTION;

ARA;

EID: 12844276579     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2004.11.004     Document Type: Article

References (53)

1. J. Yang, J. Yu, and P. Duerksen-Huges Protein kinases and their involvement in the cellular responses to genotoxic stress Mutat. Res 543 2003 31 58
2. E.H. Fisher, H. Charbonneau, and N.K. Tonks Protein tyrosine phosphatases: a diverse family of intracellular and transmembrane enzymes Science 253 1991 401 406
3. R.J. Matthews, D.B. Bowne, E. Flores, and M.L. Thomas Characterization of hematopoietic intracellular protein tyrosine phosphatases: description of a phosphatase containing and SH 2 domain and another enriched in proline, glutamic acid- serine-, and threonin-rich sequences Mol Cell Biol 12 1992 2396 2405
4. J. Plutzky, B.G. Neel, and R.D. Rosenberg Isolation of a src-homology 2-containing tyrosine phosphatase Proc Natl Acad Sci USA 89 1992 1123 1127
5. T.L. Yi, J.L. Cleveland, and J.H. Ihle Protein tyrosine phosphatase containing SH 2 domains: characterization, preferential expression in hematopoietic cells and localization in human chromosome 12p12-p13 Mol Cell Biol 12 1992 836 846
6. L.D. Shultz, P.A. Schweitzer, and T.V. Raian Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Heph) gene Cell 73 1993 1445 1454
7. H.W. Tsui, K.A. Siminovich, L. de Souza, and F.W. Tsui Motheaten and viable motheaten mice have mutations in the haematopoietic cell phosphatase gene Nat Genet 4 1993 124 129
8. K. Yoshida, S. Kharbanda, and D. Kufe Functional interaction between SHPTP1 and Lyn tyrosine kinase in the apoptotic response to DNA damage J Biol Chem 274 1999 34663 34668
9. K. Yoshida, R. Weichelbaum, S. Kharbanda, and D. Kufe Role for Lyn tyrosine kinase as a regulator of stress-activated protein tyrosine kinase activity in response to DNA damage Mol Cell Biol 20 2000 5370 5380
10. K. Yoshida, and D. Kufe Negative regulation of the SHPTP1 protein tyrosine phosphatase by protein kinase C in response to DNA damage Mol Pharmacol 60 2001 1431 1438
11. S.G. Clark, M.J. Stern, and C. Horowitz HOUR elegans cell-signaling gene sem-5 encodes a protein with SH2 and SH3 domains Nature 356 1992 340 344
12. S. Grazide, A. Maeste, and R.J. Veldman Ara-C and daunorubicin-induced recruitment of Lyn in sphingoyelinase-enriched membrane rafts FASEB J 16 2002 1685 1687
13. Z.M. Yuan, J. Huang, S.-K. Kraeft, L.B. Chen, S. Kharbanda, and D. Kufe Interaction of cyclin-dependent kinase 2 and the Lyn tyrosine kinase in cells treated with 1-beta-D-arabinofuranosylcytosine Oncogene 13 1996 939 946
14. E.L. Sievers, F.R. Appelbaum, and R.T. Spielberger Selective ablation of acute myeloid leukemia using antibody-targeted chemotherapy: a phase I study of an anti-CD33 caliceamicin immunoconjugate Blood 93 1999 3678 3684
15. E. Feldman, M. Kalaycio, and G. Weiner Treatment of relapsed or refractory acute myeloid leukemia with humanized anti-CD33 monoclonal antibody HuM195 Leukemia 17 2003 314 318
16. J.D. Griffin, D. Linch, K. Sabbath, P. Larcom, and S.F. Schlossman A monoclonal antibody reactive with normal and leukemic human myeloid progenitor cells Leuk Res 8 1984 521 527
17. S.D. Freeman, S. Kelm, E.K. Barber, and P.R. Crocker Characterization of CD33 as a new member of the sialoadhesin family of cellular interaction molecules Blood 85 1995 2005 2012
18. T. Ulyanova, J. Blasioli, T.A. Woodford-Thomas, and M.L. Thomas The sialoadhesin CD33 is a myeloid-specific inhibitory receptor Eur J Immunol 29 1999 3440 3449
19. V.C. Taylor, C.D. Buckley, M. Douglas, A.J. Cody, D.L. Simmons, and S.D. Freeman The myeloid-specific scialic acid-binding receptor, CD33, associates with the protein tyrosine phosphatases, SHP-1 and SHP-2 J Biol Chem 274 1999 11505 11512
20. S.P. Paul, L.S. Taylor, E.K. Sansbury, and D.W. McVicar Myeloid specific human CD33 is an inhibitory receptor with differential ITIM function in recruiting the phosphatases SHP-1 and SHP-2 Blood 96 2000 483 490
21. C. Vitale, C. Romagnani, M. Falco, M. Ponte, and M.C. Mingari Engagement of p75/AIRMI or CD33 inhibits the proliferation of normal or leukemic myeloid cells Proc Nat Acad Sci USA 96 1999 15091 15096
22. C. Vitale, C. Romagnani, A. Puccetti, D. Olive, and M.C. Mingari Surface expression and function of p75/AIRM-1 or CD33 in acute myeloid leukemias: engagement of CD33 induces apoptosis of leukemic cells Proc Nat Acad Sci USA 98 2001 5764 5769
23. M.C. Mingari, C. Vitale, C. Romagnani, M. Falco, and L. Moretta p75/AIRM1 and CD33, two sialoadhesin receptors that regulate the proliferation or the survival of normal and leukemic myeloid cells Immunol Rev 181 2001 260 268
24. G. Ferlazzo, G.M. Spaggiari, C. Semino, G. Melioli, and L. Moretta Engagement of CD33 surface molecule prevents the generation of dendritic cells from both monocytes and CD34+ myeloid precursors Eur J Immunol 30 2000 827 831
25. S. Qin, and H. Yamamura Up-regulation of Syk activity during HL60 cell differentiation into granulocyte but not into monocyte/macrophage-lineage Biochem Biophys Res Commun 236 1997 697 701
26. M. Tsubokawa, Y. Tohyama, and K. Tohyama Interleukin-3 activates Syk in a human myeloblastic leukemia cell line, AML-193 Eur J Biochem 249 1997 792 796
27. E.M. Raeder, P.J. Mansfield, V. Hinkovska-Galcheva, J.A. Shayman, and L.A. Boxer Syk activation initiates downstream signaling events during human polymorphonuclear leukocyte phagocytosis J Immunol 163 1999 6785 6793
28. L.B. Dustin, D.R. Plas, and J. Wong Expression of dominant-negative src-homology domain 2-containing protein tyrosine phosphatase-1 results in increased Syk tyrosine kinase activity and B cell activation J Immunol 162 1999 2717 2724
29. S. Kraft, N. Katoh, N. Novak, S. Koch, and T. Bieber Unexpected functions of FcepsilonRI on antigen-presenting cells Int Arch Allergy Immunol 124 2001 35 37
30. B. Cambien, M. Pomeranz, M.A. Millet, B. Rossi, and A. Schmid-Alliana Signal transduction involved in MCP-1-mediated monocytic transendothelian migration Blood 97 2001 359 366
31. Z.A. Stewart, and J.A. Pieterpol Syk: a new player in the field of breast cancer Breast Cancer Res 3 2001 5 7
32. P.J. Coopman, M.T. Do, and M. Barth The Syk tyrosine kinase suppresses malignant growth of human breast cancer cells Nature 406 2000 742 747
33. Y. Yuan, R. Mendez, A. Sahin, and J.L. Dai Hypermethylation leads to silencing of the SYK gene in human breast cancer Cancer Res 61 2001 5558 5561
34. P.A. Goodman, C.M. Wood, A. Vassiley, C. Mao, and F.M. Uckun Spleen tyrosine kinase (Syk) deficiency in childhood pro-B cell acute lymphoblastic leukemia Oncogene 20 2001 3969 3978
35. Y. Kuno, A. Abe, and N. Emi Constitutive kinase activation of the TEL-Syk fusion gene in myelodysplastic syndrome with t(9;12)(q22;p12) Blood 97 2001 1050 1055
36. A.C. Lankester, G.M. van Schijndel, C.E. van der Schoot, M.H. van Oers, C.J. van Noesel, and R.A. van Lier Antigen receptor nonresponsiveness in chronic lymphocytic leukemia B cells Blood 86 1995 1090 1097
37. A.C. Lankester, G.M. van Schijndel, N.G. Pakker, R.H. van Oers, and R.A. van Lier Antigen receptor function in chronic lymphocytic leukemia B cells Leuk Lymphoma 24 1996 27 33
38. B.J. Vilen, S.J. Famiglietti, A.M. Carbone, B.K. Kay, and J.C. Cambier B cell antigen receptor desensitization: disruption of receptor coupling to tyrosine kinase activation J Immunol 159 1997 231 243
39. M.M. Hamawy, C. Fischler, J. Zhang, and R.P. Siraganian Fc epsilon RI aggregation induces tyrosine phosphorylation of a novel 72 kDa protein downstream of Syk Biochem Biophys Res Commun 239 1997 670 675
40. R. Xu, R. Seger, and I. Pecht Cutting edge: extracellular signal-regulated kinase activates syk: a new potential feedback regulation of Fc epsilon receptor signaling J Immunol 163 1999 1110 1114
41. H. Ma, T.M. Yankee, J. Hu, D.J. Asai, M.L. Harrison, and R.L. Geahlen Visualization of Syk-antigen receptor interactions using green fluorescent protein: differential roles for Syk and Lyn in the regulation of receptor capping and internalization J Immunol 166 2001 1507 1516
42. C. Ebel, R.E. Schmidt, and M. Hundt Signal transduction via both human low-affinity IgG Fc receptors, Fc gamma RIIa and Fc gamma RIIIb, depends on the activity of different families of intracellular kinases Immunobiology 203 2001 616 628
43. C.L. Law, S.P. Sidorenko, and K.A. Chandran CD22 associates with protein tyrosine phosphatase 1C, Syk and phospholipase C-gamma 1 upon B cell activation J Exp Med 183 1996 547 560
44. J.M. Tuscano, P. Engel, T.F. Tedder, A. Agarval, and J.H. Kehrl Involvement of p72syk kinase, p53/56lyn kinase and phosphatidyl inositol-3 kinase in signal transduction via the human B lymphocyte antigen CD22 Eur J Immunol 26 1996 1246 1252
45. J. Yohannan, J. Wienands, K.M. Coggeshall, and L.B. Justement Analysis of tyrosine phosphorylation-dependent interactions between stimulatory effector proteins and the B cell co-receptor CD22 J Biol Chem 274 1999 18769 18776
46. K.L. Otipoby, K.E. Draves, and E.A. Clark CD22 regulates B cell receptor-mediated signals via two domains that independently recruit Grb2 and SHP-1 J Biol Chem 276 2001 44315 44322
47. L. Balaian, and E.D. Ball Direct effect of bispecific anti-CD33 × anti-CD64 antibody on proliferation and signaling in myeloid cells Leuk Res 25 2001 1115 1125
48. L. Balaian, R.K. Zhong, and E.D. Ball The inhibitory effect of anti-CD33 monoclonal antibodies on AML cells growth correlates with Syk and/or ZAP-70 expression Exp Hematol 5 2003 363 371
49. B.L. Pike, and W.A. Robinson Human bone marrow colony growth in agar gel J Cell Physiol 78 1970 77 79
50. L. Balaian, and E.D. Ball Inhibition of acute myeloid leukemia cell growth by mono-specific and bi-specific anti-CD33 × anti-CD64 antibodies Leuk Res 28 2004 821 829
51. N. Nara, J.E. Curtis, J.S. Senn, D.L. Trichler, and E.A. McCulluch The sensitivity to cytosine arabinoside of the blast progenitors of acute myeloblastic leukemia Blood 3 1986 762 769
52. P.C. Caron, L.T. Lai, and D.A. Scienberg Inteleukin-2 enhancement of cytotoxicity by humanized monoclonal antibody M195 (anti-CD33) in myelogenious leukemia Clin Cancer Res 1 1995 63 70
53. E.L. Sievers Targeted therapy of acute myeloid leukemia with monoclonal antibodies and immunoconjugates Cancer Chemother Pharmacol 46 2000 18 22